What is she best known for?
The fields of study she is best known for:
- Acquired immunodeficiency syndrome
- Virus
- Internal medicine
Virology, Virus, Immunology, Viral replication and Drug resistance are her primary areas of study.
Her Virology study combines topics in areas such as Mutation and Mutant.
Her Immunology research is multidisciplinary, relying on both Chemotherapy and Genotype.
Her Viral disease research includes themes of Viremia and Acquired immunodeficiency syndrome.
Her Acquired immunodeficiency syndrome study integrates concerns from other disciplines, such as Regimen and Gynecology.
Her studies in Pediatrics integrate themes in fields like Pre-exposure prophylaxis and Emtricitabine.
Her most cited work include:
- Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. (2088 citations)
- Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. (2088 citations)
- Proliferation of cells with HIV integrated into cancer genes contributes to persistent infection (405 citations)
What are the main themes of her work throughout her whole career to date?
Her primary areas of investigation include Virology, Immunology, Drug resistance, Virus and Internal medicine.
Lisa M. Frenkel interconnects Nevirapine, Antiretroviral therapy and Genotype in the investigation of issues within Virology.
Her research investigates the connection with Immunology and areas like Acquired immunodeficiency syndrome which intersect with concerns in Pediatrics.
As a member of one scientific family, Lisa M. Frenkel mostly works in the field of Drug resistance, focusing on Molecular biology and, on occasion, Mutant.
Her study in Randomized controlled trial is interdisciplinary in nature, drawing from both Placebo and Pre-exposure prophylaxis.
Her work carried out in the field of Emtricitabine brings together such families of science as Gynecology and Serodiscordant.
She most often published in these fields:
- Virology (76.07%)
- Immunology (44.87%)
- Drug resistance (37.18%)
What were the highlights of her more recent work (between 2014-2021)?
- Virology (76.07%)
- Drug resistance (37.18%)
- HIV drug resistance (14.10%)
In recent papers she was focusing on the following fields of study:
Her primary areas of investigation include Virology, Drug resistance, HIV drug resistance, Antiretroviral therapy and Internal medicine.
Her work in Viral replication and Virus is related to Virology.
Her Drug resistance research is multidisciplinary, incorporating elements of Dolutegravir, Acquired immunodeficiency syndrome, Point mutation, Lamivudine and Resistance mutation.
In general Internal medicine, her work in Randomized controlled trial and Confidence interval is often linked to Minor linking many areas of study.
Her biological study spans a wide range of topics, including Hazard ratio, Proportional hazards model and Emtricitabine.
Her work deals with themes such as Open label, Gynecology, Gerontology and Serodiscordant, which intersect with Family medicine.
Between 2014 and 2021, her most popular works were:
- HIV-1 drug resistance before initiation or re-initiation of first-line antiretroviral therapy in low-income and middle-income countries: a systematic review and meta-regression analysis (166 citations)
- HIV-1 drug resistance before initiation or re-initiation of first-line antiretroviral therapy in low-income and middle-income countries: a systematic review and meta-regression analysis (166 citations)
- Risk of Drug Resistance Among Persons Acquiring HIV Within a Randomized Clinical Trial of Single- or Dual-Agent Preexposure Prophylaxis (74 citations)
In her most recent research, the most cited papers focused on:
- Internal medicine
- Virus
- Acquired immunodeficiency syndrome
Lisa M. Frenkel mainly focuses on Drug resistance, Virology, Antiretroviral therapy, Internal medicine and HIV drug resistance.
Her research on Drug resistance also deals with topics like
- Acquired immunodeficiency syndrome which connect with Meta-regression, Meta-analysis and Regimen,
- Reverse-transcriptase inhibitor that intertwine with fields like Lamivudine.
Lisa M. Frenkel has included themes like Resistance mutation, Nelfinavir, Point-of-care testing and Polymerase chain reaction in her Virology study.
She combines subjects such as Proviral integration, Gene, Viral replication and Longevity with her study of Antiretroviral therapy.
Her study focuses on the intersection of HIV drug resistance and fields such as Genotyping with connections in the field of Sanger sequencing, Medical physics and Virus.
Lisa M. Frenkel focuses mostly in the field of Randomized controlled trial, narrowing it down to topics relating to Emtricitabine and, in certain cases, Pre-exposure prophylaxis, Bacterial vaginosis, Gardnerella vaginalis and Dysbiosis.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
